The latest from Orpyx®.

Smart Insoles: Assessing their Clinical Potential

Orpyx’s SurroSense Rx® was recently mentioned LER Magazine. Lower Extremity Review or LER Magazine fills the lower extremity information gap for practitioners in the fields of Podiatry, Physical Therapy, O&P Pedorthics, and Orthopaedics. The article discusses how athletes have been quick to embrace smart insoles and the biomechanical data generated by the devices’ embedded sensors. However, experts believe smart insoles may also have potential clinical applications for patients with foot health problems, such as diabetic neuropathy.

read more

Could New Wearable Technologies Help Replace Lost Or Impaired Plantar Pressure Proprioception?

Orpyx’s SurroGait Rx™ was recently mentioned in Volume 29 – Issue 3 – March 2016 of Podiatry Today. Podiatry Today is an award-winning, premier publication that emphasizes informative clinical features and columns as well as practice management articles. The authors Dr. Breanne Everett – Orpyx’s CEO and Co-Founder, Dr. Asmussen, and Dr. Armstrong discuss changing perspectives on neuroplasticity and the evolution of sensory substitution, and how these trends have led to wearable technology with potential benefits in this high-risk population.

read more

Patent granted for Orpyx technology in New Zealand

Orpyx Medical Technologies Inc. announced today that the New Zealand intellectual property office has awarded Orpyx an important patent related to the company’s foundation technology. The “Peripheral Sensory and Supersensory Replacement System” patent covers key inventions used in both Orpyx’s SurroSense Rx® product and future products, such as SurroGait Rx (TM), in New Zealand.

read more

Orpyx LogR™ to be used to investigate markers for cardiovascular disease

Orpyx Medical Technologies Inc. today announced a clinical trial agreement with Brigham and Women’s Hospital, a teaching affiliate of Harvard Medical School in Boston, USA. The study will use the Orpyx LogR plantar pressure research system to measure gait and balance parameters in a variety of patients with cardiac and vascular disorders in an attempt to correlate global musculoskeletal changes (as represented by balance/foot pressure physiology) to discrete subsets of cardiovascular disease.

read more

Orpyx Welcomes New Director

Orpyx Medical Technologies Inc. announced today that David Taylor has joined its Board of Directors, effective immediately. Mr. Taylor is the President of Resman Holdings Ltd., an investment firm with a diverse portfolio of investments across industries. 

read more

Orpyx’s LogR Steps Up for Athletes

The LogR from Orpyx Medical Technologies Inc. (“Orpyx”) was featured on The Discovery Channel’s hit television series, Daily Planet. The LogR system is a mobile kit targeted for research-focused plantar pressure measurement – collecting data in real time, in the real world. Samuel Blades, PhD candidate from the University of Victoria’s Department of Exercise was approached by the television station to record a segment on his applied sports science research. As described in the segment, the progress made to date is nothing short of “revolutionary”.

read more

Orpyx® Launches Fully Redesigned Website

Orpyx Medical Technologies Inc. (“Orpyx”) is pleased to announce the launch of its fully revamped website: The website has been redesigned with our customer needs in mind. We’ve focused on making the site easier to navigate, more impactful and providing greater support resources.

read more

Diabetic Foot Conference Weighs Offloading Issues

Orpyx was recently mentioned in the July 2015 edition of the Lower Extremity Review. At the International Working Group on the Diabetic Foot in the Netherlands, pressure offloading was a hot topic. Lower Extremity Review author, Cary Groner, provides a synopsis of the conference and what clinicians are suggestion for best practice recommendations on offloading. They also discuss Orpyx’s smart insoles!

read more

Consumer Health Technologies You Should Be Using

Technological advancements have ushered in a new dawn of health and fitness, where tracking our well-being can be done via our smartphones and tablets. Today, we have thousands of health applications for Android and iOS devices that allow us to immediately count the calories we have burnt and the distance we have ran, walked or cycled. In a 2014 report entitled, mHealth App Developer Economics, it revealed that the worldwide revenue for mobile health app reached $2.4 billion in 2013, and they expect that it will grow to $26 billion by the end of 2017 But, apart from mobile applications, there are other health-related technologies that are also garner a lot of press within the tech domain. We have listed some of the buzz tech devices that you should seriously consider purchasing in the coming months.

read more

SurroSense Rx Praised at 48 Hrs in the Hub

Orpyx Medical Technologies Inc. (“Orpyx”) participated in the pitch competition at the 48 Hours in the Hub event, an annual intensive two-day program in Cambridge/Boston. Orpyx’s President, Lew Turnquist, competed against other Canadian companies in the Life Sciences/ Health IT stream and was awarded the prize for “Coolest Technology”. The award was delivered by Gaurav Jain, who was recently named one of Forbes’ 30 under 30 in Venture Capital 2015.

read more

Have Your Cake & Eat It Too (Sugar-Free, of Course)!

It’s no secret that diabetes is a difficult disease to manage with many co-morbid conditions associated with it. One of the most common complications related to the disease is peripheral neuropathy. Patients with diabetes can lose sensation in their feet, which can lead to ulcers, infection and in many cases amputation.

read more

“An Ounce of Prevention….

As we remember the now famous quote from Benjamin Franklin its clear to see that the idea of “Prevention” is not new. It’s an excellent idea and always has been.

read more

2014 Fundica Funding Roadshow Winner

Orpyx® presented to a funding panel in Edmonton, Alberta and was awarded top honours. The Fundica Fundraising Roadshow is an opportunity for companies to pitch their innovative product to an esteemed panel of VC, banks and government organizations.

read more

Orpyx Names New Vice President of Sales & Marketing

Orpyx Medical Technologies Inc. announced today that John Jahrstorfer has joined the team as Vice President of Sales & Marketing. In this role, Jahrstorfer will lead the company’s sales and marketing team and drive Orpyx’s launch of the SurroSense Rx system worldwide. Jahrstorfer will be based in New England.

read more

The Power of Partnerships Prevails

Mitacs, Own the Podium, Orpyx Medical Technologies (“Orpyx”), the University of Victoria and the Canadian Sport Institute Pacific have joined forces to provide a new opportunity for applied sport science research. These forward-thinking organizations are collaborating on a project with PhD candidate Samuel Blades from the University of Victoria’s Department of Exercise Science, Physical & Health Education.

read more

Orpyx® Receives Funding Support From WINN Initiative

Orpyx® Medical Technologies Inc. has been announced as one of the twenty-seven companies in western Canada to receive funding under the Western Innovation (WINN) Initiative. WINN is a government program committed to creating jobs, promoting economic growth, and maintaining Canada’s competitive advantage in the global marketplace. In Alberta, WINN will be funding eleven projects totaling $6.81 million to support the advancement of a healthy economy.

read more

Orpyx Receives Funding Support From WINN Initiative

Orpyx Medical Technologies Inc. has been announced as one of the twenty-seven companies in western Canada to receive funding under the Western Innovation (WINN) Initiative. WINN is a government program committed to creating jobs, promoting economic growth, and maintaining Canada’s competitive advantage in the global marketplace.  In Alberta, WINN will be funding eleven projects totaling $6.81 million to support the advancement of a healthy economy.

read more

Orpyx Receives CE Mark Approval for SurroSense Rx™ System

Orpyx Medical Technologies Inc. (“Orpyx”) gains CE Mark approval for its flagship device, the SurroSense Rx™ System.  As the requirement for certain medical devices sold in the European Union, this CE Mark approval will enable Orpyx to advance sales into this market as well as conduct clinical trials.  The company anticipates international distribution of the device early 2014.

read more

Orpyx Awarded Top Honours at 2013 TEC Edmonton VenturePrize

Orpyx® Medical Technologies was announced the grand-prize winner at the 2013 TEC Edmonton VenturePrize Awards in the Fast Growth category. This win marks three competition firsts in over a decade including: the first ever female-led company to win, first winner from Calgary, and the first company to win Student and Fast Growth competitions back-to-back.

read more

U.S. Patent No. 10,004,428 - June 2018
U.S. Patent No. 9,778,131 B2 - October 2017
U.S. Patent No. D740,950 S - October 2015
Australia Patent No. 2011320072 - May 2016
Japan Patent No. 6004444 - October 2016
New Zealand Patent No. 611197 - November 2015

Subscribe to our newsletter
* indicates required